SCHEMBL7787997

SCHEMBL7787997

CCc1c(-c2cccc(O)c2)noc1-c1cccc(O)c1.CCc1c(-c2cccc(O)c2)noc1-c1ccccc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.42
ESR2 Q92731 6/20 0.42
HSP90AB1 P08238 1/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
DUSP3 P51452 1/20 0.38
MEN1 O00255 2/20 0.37
NPC1 O15118 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
HPGD P15428 2/20 0.37
NFKB1 P19838 2/20 0.37
CYP2C19 P33261 2/20 0.37
RAB9A P51151 2/20 0.37
NFKB2 Q00653 2/20 0.37
KMT2A Q03164 2/20 0.37
RELA Q04206 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PLK4 O00444 1/20 0.37
ROCK2 O75116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730471 0.97 ESR1 (0.44) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL6306419 0.93 ESR1 (0.47) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL5729500 0.90 ESR1 (0.42) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL15554905 0.87 DUSP3 (0.48) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL5730462 0.83 ESR2 (0.43) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL5729008 0.83 HSD17B1 (0.47) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL5729094 0.81 ESR1 (0.45) ESR1ESR2HSP90AB1MAPTALDH1A1
SCHEMBL5729937 0.81 ESR1 (0.50) ESR1ESR2HSP90AB1MAPTDUSP3
SCHEMBL5728965 0.78 ESR1 (0.54) ESR1ESR2HSP90AB1MAPTDUSP3
SCHEMBL5729950 0.76 ESR2 (0.48) ESR1ESR2HSP90AB1DUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010036956-A1 Estrogen receptor modulators HUEBNER VERENA D (US) 2001-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010036956-A1 Estrogen receptor modulators ESR1, ESR2, GPER1 ESR1 1/4885ESR2 2/4885HSP90AB1 2701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.